The endothelium modulates vascular tone by releasing nitric oxide, which is a potent vasodilator and inhibitor of platelet aggregation. Together with prostacyclin, the endogenous nitrate nitric oxide has an important protective role in preventing vasospasm and thrombus formation. In addition, the endothelium is a source of contracting factors such as endothelin-1, thromboxane A2 and endoperoxides. Due to its strategic anatomical position, the endothelium is a primary target for injurious stimuli and cardiovascular risk factors. Low density lipoproteins reduce endothelium-dependent relaxation and enhance endothelium- dependent contraction. The same pattern of endothelial dysfunction occurs in hypercholesterolaemia and atherosclerosis. These alterations of endothelial function may contribute to vasospasm, ischaemia and thrombus formation, which are common events in patients with atherosclerotic vascular disease.
References
1.
Furchgott RF , Zawadzki JVThe obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980; 299: 373-76.
Vanhoutte PMEndothelium and control of vascular function . Hypertension1989; 13: 658-67.
5.
Lüscher TFEndothelial vasoactive substances and cardiovascular disease. Basel: S Karger Publisher AG, 1988 : 1-133.
6.
Rubanyi GM, Romero JC, Vanhoutte PMFlow-induced release of endothelium-derived relaxing factor. Am J Physiol1986; 250: H1145-49.
7.
Angus JA, Cocks TMThe half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture. J Physiol1987; 388: 71-81.
8.
Rubanyi GM, Vanhoutte PMOxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol1986; 250: H815-21.
9.
Rubanyi GM, Vanhoutte PMSuperoxide anions and hyperoxia inactivate endothelium-derived relaxing factor . Am J Physiol1986; 250: H822-27.
10.
Palmer Rmi, Ferrige AG, Moncada S.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987; 327: 524-26.
11.
Furchgott RF , Khan MTSome properties of endothelium-derived relaxing factor (edrf) released from endothelial cells of rabbit aorta (Abstract). Fed Proc1986; 45: 425.
12.
Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA1987; 84: 9265-69.
13.
Myers PR, Minor RL Jr, Guerra R. Jr, Bates JN, Harrison DGVasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature1990; 345: 161-63.
14.
Schmitt Hhhw , Nau H., Wittfoht W. et al. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol1988; 154: 213-16.
Richard V., Tanner FC, Tschudi M., Lüscher TFDifferent activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol1990; 259: H1433-39.
17.
Rees DD, Palmer Rmj, Moncada S.Role of endothelium-derived nitric oxide in the regulation of blood pressure . Proc Natl Acad Sci USA1989; 86: 3375-78.
18.
Moore PK, Al-Swayeh OA, Chong Nws, Evans RA, Gibson A.L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol1990; 99: 408-12.
19.
Bredt DS, Snyder SHIsolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA1990; 87: 682-85.
Hibbs JB, Taintor RR, Vavrin Z., Rachlin EMNitric oxide: a cytotoxic activated macrophage molecule. Biochem Biophys Res Commun1988; 157: 87-94.
22.
Wood KS, Buga GM, Byrns RE, Ignarro LJVascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem Biophys Res Commun1990; 170: 80-88.
23.
Knowles RG, Palacios M., Palmer Rmj, Moncada S.Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA1989; 86: 1-4.
24.
Holzmann S.Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucl Res1982; 8: 409-19.
25.
Rapoport RM , Murad F.Endothelium-dependent and nitrovasodilator induced relaxation of vascular smooth muscle: role of cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res1983; 9: 281-96.
26.
Martin W., Villani GM, Jothianandan D., Furchgott RFSelective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther1985; 232: 708-16.
27.
Rapoport RM , Murad F.Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res1983; 52: 352-57.
28.
Busse R., Lückhoff A., Bassenge E.Endothelium-derived relaxant factor inhibits platelet activation. Naunyn-Schmiedebergs Arch Pharmacol1987; 336: 566-71.
29.
Azuma H., Ishikawa M., Sekizaki S.Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol1986; 88: 411-15.
30.
Moncada S., Vane JRPharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev1979; 30: 293-331.
31.
Moncada S., Herman AG, Higgs EA, Vale C.Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thrombosis Res1977; 11: 323-44.
32.
Lüscher TF, Romero JC, Vanhoutte PMBioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats. J Hypertension1986; 4 (suppl 6): 81-83.
33.
Nakahata N. , Suzuki T.Effects of prostaglandin E1, I2, and isoproterenol on the tissue cyclic AMP content in longitudinal muscle of rabbit intestine . Prostaglandins1981; 22: 159-65.
34.
Shimokawa H. , Flavahan NA, Lorenz RR, Vanhoutte PMProstacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig . Br J Pharmacol1988; 95: 1197-1203.
35.
Macdonald PS , Read MA, Dusting GJSynergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res1988; 49: 437-49.
36.
De Mey JG, Claeys M., Vanhoutte PMEndothelium-dependent inhibitory effects of acetylcholine, adenosine diphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther1982; 222: 166-73.
37.
Boulanger C. , Hendrickson H., Lorenz RR, Vanhoutte PMRelease of different relaxing factors by cultured porcine endothelial cells. Circ Res1989; 64: 1070-78.
38.
Hoeffner U. , Feletou M., Flavahan NA, Vanhoutte PMCanine arteries release two different endothelium-derived relaxing factors. Am J Physiol1989; 257: H330-33.
39.
Feletou M., Vanhoutte PMEndothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol1988; 93: 515-24.
40.
Komori K., Lorenz RR, Vanhoutte PMNitric oxide, acetylcholine, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol1988; 255: H207-12.
41.
Tare M., Parkington HC, Coleman HA, Neild TO, Dusting GJHyperpolarisation and relaxation of arterial smooth muscle caused by NO derived from the endothelium. Nature1990; 346: 69-71.
42.
Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y., Nelson MTHyperpolarising vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science1989; 245: 177-80.
43.
Gerritsen ME , Nganele DM, Rodrigues AMCalcium ionophore (A23187)- and arachidonic acid-stimulated prostaglandin release from microvascular endothelial cells: effects of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther1987; 240: 837-46.
44.
Busse R., Foerstermann U., Matsuda H., Pohl U.The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia. Pfluegers Arch1984; 401: 77-83.
45.
Rubanij GM, Vanhoutte PMHypoxia releases a vasoconstrictor substance from the canine vascular endothelium . J Physiol1985; 364: 45-56.
46.
Iqbal A., Vanhoutte PMFlunarizine inhibits endothelium-dependent hypoxic facilitation in canine coronary arteries through an action on vascular smooth muscle. Br J Pharmacol1988; 95: 789-94.
47.
Rakugi H., Tabuchi Y., Nakamura M. et al. Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem Biophys Res Commun1990; 169: 973-77.
48.
Liu J., Casley DJ, Nayler WGIschaemia causes externalization of endothelin-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun1989 ; 164: 1220-25.
49.
Liu J., Chen R., Casley DJ, Nayler WGIschemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol1990; 258: H829-35.
50.
Miller VM, Vanhoutte PMEndothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase in canine veins. Am J Physiol1985; 248: H432-37.
51.
Singer HA, Peach MJEndothelium-dependent relaxation of rabbit aorta. II: Inhibition of relaxation stimulated by methacholine and A 23187 with antagonists of arachidonic acid metabolism. J Pharmacol Exp Ther1983; 227: 796-801.
52.
Yang Z., von Segesser L., Bauer E., Stulz P., Turina M., Lüscher TFDifferent activation of endothelial L-arginine and cyclooxygenase pathway in human internal mammary artery and saphenous vein. Circ Res1991: 68: 52-60.
53.
Rosen GM, Freeman BADetection of superoxide generated by endothelial cells. Proc Natl Acad Sci USA1984; 81: 7269-73.
54.
Katusic ZS, Vanhoutte PMSuperoxide anion is an endothelium-derived contracting factor. Am J Physiol1989; 257: H33-37.
55.
Yanagisawa M., Kurihara H, Kimura et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988; 332: 411-15.
56.
Yanagisawa M., Inoue A., Ishikawa T. et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide . Proc Natl Acad Sci USA1988; 85: 6964-67.
57.
Kimura S., Kasuya Y., Sawamura T. et al. Structure-activity relationships of endothelin: importance of the c-terminal moiety. Biochem Biophys Res Commun1988; 156: 1182-86.
58.
Kimura S., Kasuya Y., Sawamura T. et al. Conversion of big endothelin-1 to 21-residue endothelin-1 is essential for expression of full vasoconstrictor activity: structure-activity relationships of big endothelin-1. J Cardiovasc Pharmacol1989; 13 (suppl 5): 5-7.
59.
Watanabe T., Kusomoto K., Kitayoshi T., Shimamoto N.Positive inotropic and vasoconstrictive effects of endothelin-1 in vivo and in vitro experiments: characteristics and the role of L-type calcium channels . J Cardiovasc Pharmacol1989; 13 (suppl 5): 108-11.
60.
Suzuki N., Matsumoto H., Kitada C. et al. Immunoreactive endothelin-1 in plasma detected by a sandwich-type enzyme immunoassay. J Cardiovasc Pharmacol1989; 13 (suppl 5): 151-52.
61.
Yoshimoto S. , Ishizaki Y., Mori A., Sasaki T., Takakura K., Murota S.The role of cerebral microvessel endothelium in regulation of cerebral blood flow through production of endothelin-1 (Abstract) . J Vasc Med Biol1990; vmr-2: 178.
62.
Clozel M., Fischli W., Guilly C.Specific binding of endothelin in human vascular smooth muscle cells in culture . J Clin Invest1989; 83: 1758-61.
63.
Miller VM, Komori K., Burnett JC, Vanhoutte PMDifferential sensitivity to endothelin in canine arteries and veins. Am J Physiol1989; 257: H1127-31.
64.
Goto K., Kasuya Y, Matsuki et al. Endothelin activates the dihydroperidine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. Proc Natl Acad Sci USA1989; 86: 3915-18.
65.
Van Renterghem C., Vigne P., Barhanin J., Schmid-Alleana A., Frelin C., Lazdunski M.Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem Biophys Res Commun1988; 157: 977-85.
66.
Kiowski W., Lüscher TF, Linder L., Bühler FREndothelin-1 induced vasoconstriction in man: reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor . Circulation1991; 83: 469-75.
67.
Dohi Y., Lüscher TFHypertension differentially affects intraluminal and extraluminal activation of the endothelium (Abstract). Hypertension1990; 16: 315.
68.
Warner TD, de Nucci G., Vane JRRat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol1989; 1590: 325-26.
69.
Warner TD, Mitchell JA, de Nucci G., Vane JREndothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol1989; 13 (suppl 5): 85-88.
70.
Yang Z., Bühler FR, Diederich D., Lüscher TFDifferent effects of endothelin of caclic AMP- and cyclic GMP-mediated relaxation in human arteries and veins: comparison with norepinephrine. J Cardiovasc Pharmacol1989; 13 (suppl 5): 129-31.
71.
Boulanger C. , Lüscher TFRelease of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest1990; 85: 587-90.
72.
Faggiotto A. , Ross R., Harker L.Studies of hypercholesterolemia in the nonhuman primate. I: Changes that lead to fatty streak formation. Arteriosclerosis1984; 4: 323-40.
73.
Shimokawa H. , Tomoike H., Nabeyama S.Coronary artery spasm induced in atherosclerotic miniature swine. Science1983; 221: 560-62.
74.
Ylä-Herttuala S., Palinski W., Rosenfeld ME et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest1989; 84: 1086-95.
75.
Kugiyama K. , Kerns SA, Morrisett JD, Roberts R., Henry PDImpairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature1990; 344: 160-62.
76.
Simon BC, Cunningham LD, Cohen RAOxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest1990; 86: 75-79.
77.
Tanner FC, Noll G., Boulanger CM, Lüscher TFOxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide . Circulation1991; 83: 2012-21.
78.
Yokoyama M. , Hirata K., Miyake R., Akita H., Ishikawa Y., Fukuzaki H.Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun1990 ; 168: 301-308.
79.
Bing R., Saeed M.The role of lysolecithin in the relaxation of vascular smooth muscle. Biosci Rep1987; 7: 783-89.
Voyta JC, Via DP, Butterfield CE, Zetter BRIdentification and isolation of endothelial cells based on their increased uptake of acetylated low density lipoproteins. J Cell Biol1984; 99: 2034-40.
82.
Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JLThe scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages . J Supromol Struct1980; 13: 67-81.
83.
Shimokawa H. , Vanhoutte PMDietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries . Circulation1988; 78: 1421-30.
84.
Shimokawa H. , Vanhoutte PMImpaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and in atherosclerosis. Circ Res1989; 64: 900-14.
Galle J., Mülsch A., Busse R., Bassenge E.Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arteriosclerosis and Thrombosis1991; 11: 198-203.
87.
Galle J., Bassenge E., Busse R.Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res1990; 676: 1287-93.
88.
Boulanger CM , Tanner FC, Hahn Awa, Lüscher TFRelease of endothelin from the porcine aortic endothelium by oxidized low density lipoproteins (Abstract). J Vasc Med Biol1990; 24: 185.
89.
Verbeuren TJ , Jordaens FH, Zonnekeyn LL, VanHove CE, Coene M-C, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I: Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries on control and hypercholesterolemic rabbits. Circ Res1986; 58: 552-64.
90.
Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DGAtherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res1986; 58: 783-89.
91.
Sellke FW, Armstrong ML, Harrison DGEndothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation1990 ; 81: 1586-93.
92.
Förstermann U., Mügge A., Alheid U., Haverich A., Frölich JCSelective attenuation of endotheliummeidated vasodilation in atherosclerotic human coronary arteries. Circ Res1988; 62: 185-90.
93.
Ludmer PL, Selwyn AP, Shook TL et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med1986; 315: 1046-51.
94.
Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation1990; 81: 491-97.
95.
Golino P., Piscione F., Willerson JT et al. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients . N Engl J Med1991; 324: 641-48.
96.
McFadden EP , Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A.Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med1991; 324: 648-54.
97.
Minor RL Jr, Myers PR, Guerra R. Jr, Bates JN, Harrison DGDiet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest1990; 86: 2109-16.
98.
Tschudi M., Richard V., Bühler FR, Lüscher TFImportance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol1991; 260: H13-20.
99.
Bult H., De Meyer Gry, Jordaens FH, Herman AGChronic exposure to exogenous nitric oxide may suppress its endogenous release (Abstract). Arch Int Pharmacodyn Ther1990 ; 305: 234.
100.
Frei B., Stocker R., Ames BNAntioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA1988; 85: 9748-52.
101.
Parthasarathy S., Young SG, Withtum JL, Pittman RC, Steinberg D.Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest1986 ; 77: 641-44.
102.
Simon BS, Haudenschild CC, Cohen RARestoration of endothelium-dependent relaxation in atherosclerotic arteries by probucol (Abstract). Circulation1990; 82 (suppl III): 171.
103.
Henry PDAnti-atherosclerotic effects of calcium antagonists: a brief review. Clin Invest Med1987; 10: 601-16.
104.
Henry PDCalcium channel blockers and atherosclerosis. J Cardiovasc Pharmacol1990; 16 (suppl I): 12-15.
105.
Habib JB, Bossaller C., Wells S., Williams C., Morrisett JD, Henry PDPreservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with calcium blocker PN 200-110. Circ Res1986; 58: 305-309.
